Skip to main content

Vyome Holdings, Inc

For the period ended Dec 31, 2024. Filed Apr 4, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Apr 4, 2025

HIND$1.59+0.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​​​
​​RESHAPE LIFESCIENCES INC.
​​​
​By:/s/ Paul F. Hickey
​​Paul F. Hickey
​​President and Chief Executive Officer

Dated: April 4, 2025

POWERS OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Paul F. Hickey and Thomas Stankovich, and each of them, as his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this report, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SignatureTitleDate
​​
/S/ paul f. hickey​President, and Chief Executive Officer (principal executive officer)​April 4, 2025
Paul F. Hickey
​​
/S/ Thomas Stankovich​Senior Vice President and Chief Financial Officer (principal financial and accounting officer)​April 4, 2025
Thomas Stankovich​
​​​
/S/ DAN W. GLADNEY​Executive Chair of the Board​April 4, 2025
Dan W. Gladney​​
​​​​​
/S/ LORI C. MCDOUGAL​Director​April 4, 2025
Lori McDougal​
​​
/S/ ARDA MINOCHERHOMJEE​Director​April 4, 2025
Arda Minocherhomjee​
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.